FindTrial
Sign In

A retrospective observational study on post covid mucormycosis

Retrospective study on patient characteristics, disease severity and outcome in post covid mucormycosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044824
Enrollment
110
Registered
2022-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B488- Other specified mycoses

Interventions

None listed

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases of post covid19 mucor mycosis 2. Confirm tissue diagnosis of Mucormycosis

Exclusion criteria

Exclusion criteria: 1. Patient with no past history of covid disease 2. Not a proven case of Mucormycosis (no tissue diagnosis)

Design outcomes

Primary

MeasureTime frame
To study the association between patient characteristics and disease severityTimepoint: Death or Discharge—

Secondary

MeasureTime frame
To study the association between patient characteristics and outcome in post covid MucormycosisTimepoint: Death or Discharge—

Countries

India

Contacts

Public ContactDr Yogendra Dadhich

SMS Medical College Jaipur

ddryogendra@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026